Atlas Trials

ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT06351644 · TERMINATED

Trial details

NCT number
NCT06351644
Sponsor
Adriana Rossi
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2024-10-02
Primary completion
2025-04-28
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.